Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Research, 22 (1). 126-.


Page, Karen, Martinson, Luke J, Fernandez-Garcia, Daniel, Hills, Allison, Gleason, Kelly LT, Gray, Molly C, Rushton, Amelia J, Nteliopoulos, Georgios, Hastings, Robert K, Goddard, Kate
et al (show 10 more authors) (2021) Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease. JCO PRECISION ONCOLOGY, 5 (5). pp. 1768-1776.


Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert
et al (show 1 more authors) (2019) Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. BREAST CANCER RESEARCH AND TREATMENT, 175 (1). pp. 149-163.


Coombes, R Charles, Howell, Sacha, Lord, Simon R, Kenny, Laura, Mansi, Janine, Mitri, Zahi, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Chap, Linnea I, Richards, Paul, Gradishar, William
et al (show 13 more authors) (2023) Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. NATURE COMMUNICATIONS, 14 (1). 4444-.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed I, Mohammed, Hisham, Rudraraju, Bharath, Menon, Suraj, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer. In: San Antonio Breast Cancer Symposium, San Antonio, USA.

This list was generated on Mon Apr 22 05:53:43 2024 BST.